Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative...

Area of Science:

• Immunology
• Transplantation Biology
• Cellular Therapy

Background:

• Allogeneic hematopoietic chimerism induces central tolerance, crucial for therapeutic applications.
• Current methods require myeloablative conditioning and risk graft-versus-host disease (GVHD).

Purpose of the Study:

• To adapt a costimulation blockade protocol for stem cell transplantation.
• To achieve hematopoietic chimerism and central tolerance without myeloablation or GVHD.

Main Methods:

• Utilized a protocol combining donor-specific transfusion (DST) with anti-CD154 monoclonal antibody (mAb).
• Administered DST, anti-CD154 mAb, and allogeneic bone marrow for stem cell transplantation.

Main Results:

• Successfully induced hematopoietic chimerism and central tolerance without myeloablation or GVHD.
• Tolerance was mediated by deletion of host alloreactive CD8+ T cells in both periphery and thymus.
• Engraftment regulation involves both allospecific and non-allospecific mechanisms.

Conclusions:

• Robust allogeneic hematopoietic chimerism and central tolerance can be established without host myeloablative conditioning.
• A peripheral transplantation tolerance protocol effectively overcomes previous limitations in stem cell transplantation.